HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Eating Disorders (Eating Disorder)

A group of disorders characterized by physiological and psychological disturbances in appetite or food intake.
Also Known As:
Eating Disorder; Appetite Disorder; Appetite Disorders
Networked: 1603 relevant articles (59 outcomes, 253 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Obesity
2. Anxiety Disorders (Anxiety Disorder)
3. Eating Disorders (Eating Disorder)
4. Bulimia (Binge Eating)
5. Weight Loss (Weight Reduction)

Experts

1. Kaye, Walter H: 21 articles (12/2015 - 02/2003)
2. de Zwaan, Martina: 19 articles (11/2015 - 05/2003)
3. Mitchell, James E: 18 articles (03/2015 - 04/2002)
4. Bulik, Cynthia M: 17 articles (01/2015 - 01/2002)
5. Treasure, Janet: 16 articles (01/2015 - 10/2002)
6. Ricca, Valdo: 16 articles (11/2014 - 04/2002)
7. Grilo, Carlos M: 15 articles (05/2013 - 03/2002)
8. Steiger, Howard: 14 articles (07/2015 - 01/2004)
9. Monteleone, Palmiero: 11 articles (01/2016 - 11/2002)
10. Iyo, Masaomi: 11 articles (01/2013 - 08/2003)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Eating Disorders:
1. Carbon MonoxideIBA
2. Serotonin (5 Hydroxytryptamine)IBA
3. Antidepressive Agents (Antidepressants)IBA
4. olanzapine (Zyprexa)FDA Link
5. topiramate (Topamax)FDA LinkGeneric
6. Insulin (Novolin)FDA Link
7. BESIBA
8. Fluoxetine (Prozac)FDA LinkGeneric
9. Fluvoxamine (Luvox)FDA LinkGeneric
04/01/2003 - "A significant reduction in binge frequency, Beck Depression Inventory scores and the eating concern, shape concern and weight concern subscales of the Eating Disorder Examination were noted for both fluvoxamine (n = 9) and placebo (n = 11) groups. "
05/01/1993 - "However, the results indicate that Fluvoxamine may have a role in the treatment of eating disorders where bingeing is a prominent symptom and that further research would be valuable. "
05/01/1993 - "Fluvoxamine: an open pilot study in moderately obese female patients suffering from atypical eating disorders and episodes of bingeing."
10/01/2000 - "In addition, treatment with fluvoxamine < or = 300 mg/day for > or = 8 weeks improved symptoms of social phobia (social anxiety disorder), post-traumatic stress disorder (PTSD), pathological gambling, compulsive buying, trichotillomania, kleptomania, body dysmorphic disorder, eating disorders and autistic disorder. "
02/01/1996 - "In both the intent-to-treat and the completer analyses, the following scales showed fluvoxamine to have a significant effect in reducing the return of bulimic behavior: (1) self-ratings: Eating Disorder Inventory (EDI)-bulimia, urges to binge in previous week and the number of actual binges in the previous week; (2) expert ratings: Psychiatric Status Rating Scales for Bulimia nervosa, Structured Interview for Anorexia and Bulimia nervosa (SIAB)-"total score," SIAB-subscale "fasting," and SIAB-subscale "vomiting." Two further variables (EDI-total score and SIAB-subscale "bulimia") showed the superior relapse prevention effects of fluvoxamine compared with placebo for the completer sample, while they did not reach significance for group-by-time interactions in the intent-to-treat sample. "
10. Levodopa (L Dopa)FDA LinkGeneric

Therapies and Procedures

1. Aftercare (After-Treatment)
2. Drug Therapy (Chemotherapy)
3. Deep Brain Stimulation
4. Hypnosis (Mesmerism)
5. Nutrition Therapy (Medical Nutrition Therapy)